OUR TESTS

GeneSeeker

We detect, determine and prevent genetic diseases

Inherited disorders are involved in 20% of infant deaths in developed countries

World Health Organization

GeneSeeker harnesses the latest DNA sequencing technology to test patients for disease causing mutations. Simultaneous analysis of hundreds of genes helps identify couples who are at high risk of having an affected child.

When used in gamete donor programs, the information provided by GeneSeeker helps to avoid combinations of donors and patients associated with a high-risk of genetic disorder.

GeneSeeker covers critical regions of the genes assessed including some areas missed by alternative tests.

GeneSeeker screening is for everyone, including healthy adults.

The American College of Medical Genetics and Genomics (ACMG) and the American College of Obstetricians and Gynecologists (ACOG) recommend that information about carrier screening be provided to all women who are pregnant or planning to become pregnant (1-2).

1. Prior, Thomas W. 2008. “Carrier Screening for Spinal Muscular Atrophy.” Genetics in Medicine: Official Journal of the American College of Medical Genetics 10 (November). The American College of Medical Genetics: 840

2. Committee Opinion No. 690 Summary: Carrier Screening in the Age of Genomic Medicine.” 2017. Obstetrics and Gynecology 129 (3): 595–96.

Why perform GeneSeeker?

These diseases have no cure,
but can now be prevented
Taken together, inherited conditions are estimated to account for 18% of paediatric hospital admissions (*)
In developed countries, they are associated with 20% of cases of child mortality (**).

(*) Kingsmore S. PLOS Currents Evidence on Genomic Tests. 2012 May 2. Edition 1. doi: 10.1371/4f9877ab8ffa9.
(**) According to the World Health Organisation (OMS)
http://www.who.int/genomics/public/geneticdiseases/en/index2.html

How is it done?

The test is carried out on DNA obtained from blood samples from the couple (man and woman or IVF patient and sperm/egg donor). Results are provided one month later. Most couples at high risk of having a child affected by a serious inherited condition are identified.

More than 80% of children with a genetic disorder are born to parents with no family history or symptoms of the disorder

Blythe SA, et al. Clin Biochem. 1984;17(5):277-283

We detect, determine and prevent genetic diseases

Play Video

What happens when a mutation is detected?

When a mutation is detected in the same gene for both members of a couple, there is an increased risk of them having a child affected by a genetic disorder.
In such cases, the options for conceiving a child who is not affected by the inherited disease include:

In vitro fertilisation treatment with Pre-implantation Genetic Testing for Monogenic disorders (PGT-M).

For the majority of inherited conditions, Juno Genetics can offer tests that reveal which embryos have inherited mutations from the parents. Only embryos predicted to be unaffected are transferred to the mother’s uterus.

Gamete donation

Couples can consider gamete donation from a donor who does not carry a mutation in the same gene as the male or female partner.

Who should use GeneSeeker test?

Knowledge Is Power

If you and your partner are carriers of the same conditions, there are important steps you can consider, together with your Doctor.

Prior to an assisted reproduction treatment: It is advised to screen for mutations using the GeneSeeker test in order to know whether there is an increased risk of inherited disease. This allows a reproductive strategy to be chosen that reduces any risk identified.

Prior to a treatment using donor eggs or semen: GeneSeeker is used to select a donor who is not a carrier of a mutation in the same gene as the member of the couple who is providing their own gametes (eggs or sperm), greatly reducing the risk of a child affected by an inherited disorder.

Before trying to become pregnant naturally: For any couple who are planning on starting a family, helping to reveal whether there is an increased risk of having a child with an inherited disease, and allowing plans to be made to reduce the risks.

Have a family history of a genetic disorder

Are at increased risk for a specific disorder based on ethnicity (for example, Ashkenazi Jewish populations)

Most carriers of genetic mutations are unaffected themselves and have no family history of inherited disease.

GeneSeeker

Process

STEP 1

Pretest genetic counseling

STEP 2

Blood sample taken at the clinic and shipped to Juno Genetics

STEP 3

Sample arrives at the laboratory and DNA is extracted and analysed

STEP 4

Test report is created and shared with your doctor

PANEL DEFINITIONS

GeneSeeker

GSK PATIENT

(Panel: GeneSeeker v1,1)

Detailed screen for mutations of high frequency and impact, including:

CFTR gene
HBB gene
HBA1/HBA2 genes
SMN1 gene
CYP21A2 gene

GSK ESSENTIAL

(Panel: GeneSeeker Essential v1.0)

Screening of genes with common mutations in the population, including:

CFTR gene
HBB gene
SMN1 gene
HBA1/HBA2 genes

GeneSeekerMatch

“Our intelligent donor selection tool, GeneSeeker Match, enables us to bring together patients and compatible donors, radically reducing the risks of inherited conditions”

The GeneSeeker test from Juno Genetics provides a powerful and exclusive computerized tool, called GeneSeeker Match. This software allows egg and sperm banks to genetically match gametes with individual recipients, avoiding combinations that have a high risk of producing a child with an inherited disorder.
This unique system provides the clinic with the opportunity to make a bank available which has been pre-screened for more than 200 genetic disorders, eliminating the vast majority of inherited disease risk.

Difference between a genetically tested bank and a non tested bank

NON TESTED BANK

A bank which is not genetically tested, uses eggs with a high risk of passing on a genetic disease

TESTED BANK

A bank genetically tested with the GeneSeeker test, reduces the risk of transmitting a genetic disease to:

Genetic diseases that are relatively common in the general population include:

G6PD deficiency is one of the most common forms of enzyme deficiency and is thought to affect more than 400 million people worldwide. It is X-linked inherited and affects individuals of all races and ethnicities. The highest prevalence rates are found in Africa, the Middle East, certain parts of the Mediterranean and certain areas of Asia. In these regions, the rate varies from 5% to 30% of the population.

An autosomal recessive disorder that mainly damages the respiratory system, but also the functioning of other organs such as the pancreas and liver. It is more common in people from northern Europe, where the incidence of cystic fibrosis is 1 in 3,200 live births. In Spain, it is estimated that 1 in 3,750 individuals suffer from the disease and the frequency of Caucasian carriers is 1 in 25 people.

This is a genodermatosis or genetic disease mainly affecting the skin; its principal manifestations are the presence of café-au-lait spots, as well as a predisposition to the development of tumours. These are usually non-cancerous (i.e. they are usually benign), although they can sometimes become malignant. Neurofibromatosis is usually diagnosed in childhood or early adulthood, and its incidence is 1 in 3,500-3,000 live newborns. In 2001, it was estimated that 13,000 people had this pathology in Spain.

this pathology is characterised by dilatation and impaired contraction of one or both ventricles of the heart. Patients usually develop congestive heart failure, which is often progressive. Arrhythmias, thromboembolism and even sudden death are common. The estimated prevalence of familial dilated cardiomyopathy is 1 in 2,500 people. It should be noted that approximately half of the cases are familial and in 40% of these, the diagnosis is genetic in origin.

Is a genetic disease caused by an alteration in chromosome 15, and it affects the proteins that form part of the connective tissue. It affects both men and women equally and, due to its autosomal dominant pattern, the probability of a patient’s children inheriting the disease is around 50%. The incidence of this syndrome is 1 in 3,000 to 5,000 people.

In addition to those described, other common inherited genetic diseases include Achondroplasia or Noonan Syndrome.

We are all carriers of recessive genetic mutations and it is likely your baby will be too. However, being a carrier of a recessive mutation does not mean that the baby will be affected by an inherited disorder. We have two copies of each of our genes (with the exception of genes on the X-chromosome for men). If you have a recessive mutation in one copy of a gene, stopping it from working properly, the other (normal) copy is sufficient to prevent the disease.

GeneSeeker results are typically ready within 4 weeks of Juno Genetics receiving your blood sample.

In the vast majority of cases, the answer is no. We have two copies of each of our genes (with the exception of genes on the X-chromosome for men). The GeneSeeker test looks at variations in the DNA which are ‘recessive’, meaning that they only cause a disease when both copies of the gene have a mutation. If you have a recessive mutation in one copy of a gene, stopping it from working properly, the other (normal) copy is sufficient to prevent the disease. However, if your partner carries a mutation in the same gene, then there is a risk that a future child could receive a defective copy from each of you, leaving them with no functioning copies of the gene, and causing them to develop an inherited disorder.

RESOURCES

Clinical documentation

900 828 420